Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Leiomyoma 4Papillomavirus Infections 3Inflammation 2Frailty 2Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Squamous Intraepithelial Lesions 1Small Cell Lung Carcinoma 1Radiodermatitis 1Prostatic Neoplasms 1Papilloma 1Low-Grade Intraepithelial Neoplasia of Cervix 1Liver Neoplasms 1Liver Cirrhosis 1Fibrosis 1Esophageal Neoplasms 1Deglutition Disorders 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Atypical Squamous Cells of the Cervix 1

Interventions

Restraint, Physical 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Human Papillomavirus DNA Tests 2Folic Acid 2Colposcopy 2epigallocatechin gallate 1Zinc Sulfate 1Vitamin B 12 1Vaginal Smears 1Papanicolaou Test 1Mindfulness-Based Stress Reduction 1Imiquimod 1High-Throughput Screening Assays 1Gelatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Atypical Squamous Cells of the Cervix × epigallocatechin gallate × Clear all
NCT07572396 2026-05-14

Phase II Study of Dysplasixâ„¢ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Amplexd Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡